We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genetix Launches new Website
News

Genetix Launches new Website

Genetix Launches new Website
News

Genetix Launches new Website

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genetix Launches new Website"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genetix, a developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, announces the launch of its’ new web site, www.genetix.com.

The new site, which offers intuitive navigation, features a new Science Center, providing access to scientific presentations, posters and images detailing the latest technological developments in cell screening and selection, genetic testing and cancer pathology, protein science, microarraying, cell and liquid dispensing.

“We’re very excited about launching the new Genetix web site, it offers our customers comprehensive information not only about our products, but also about technology developments throughout the drug discovery field,” states Hilary Latham, Marketing Manager at Genetix.

“It also provides easy-to-navigate, detailed information about our product solutions for a wide array of applications, taking the visitor through the drug discovery continuum, from target discovery, cell line selection, and cell line optimization, to cell based validation and clinical diagnostics,” Latham added.

Advertisement